Preoperative laboratory assessment of hemostasis for orthognathic surgery.

[1]  J. Wagner,et al.  Preoperative laboratory testing for the oral and maxillofacial surgery patient. , 1991, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[2]  P. Mannucci,et al.  Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. , 1990, Annals of internal medicine.

[3]  P. Ganz,et al.  Development of a Heat-Treated Factor VIII/ von Willebrand Factor Concentrate Prepared from Heparinized Plasma , 1990, Thrombosis and Haemostasis.

[4]  G. Auerswald,et al.  Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate. , 1989, The New England journal of medicine.

[5]  M. Furlan,et al.  Virus‐inactivated factor VIII concentrate prevents postoperative bleeding in a patient with von Willebrand's disease , 1988, Transfusion.

[6]  C. Ludlam,et al.  Efficacy of Heat Treatment of Factor VIII Concentrate , 1988, Vox sanguinis.

[7]  A. Parquet‐Gernez,et al.  In vitro and in vivo Evaluation of a Factor VIII Concentrate Heat‐Treated to Inactivate HTLV‐III/LAV Viruses , 1987 .

[8]  P. Mannucci,et al.  Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. , 1987, The New England journal of medicine.

[9]  E. Gomperts.  Procedures for the inactivation of viruses in clotting factor concentrates , 1986, American journal of hematology.